Active ingredients: salbutamol
What it is used for
For the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Inhalation
- Store below 30 degrees Celsius
- Protect from direct sunlight
- Lifetime is 2 Years.
Always read the label. If symptoms persist see your healthcare professional.
Homogenous creamy-white to greyish-white coloured suspension.
Do I need a prescription?
This medicine is available from a pharmacy without prescription. It is Schedule 3: Pharmacist Only Medicine.
Is this medicine subsidised?
This medicine may be subsidised which may make it cheaper. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient salbutamol
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Airomir Autohaler Inhaler - myDr.com.au
Airomir Autohaler Inhaler - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Asthma action plans- video
Asthma action plans detail what to do in an asthma attack and when to use medications including preventers and relievers to control asthma symptoms.
Read more on myVMC – Virtual Medical Centre website
COPD: treatment and management - myDr.com.au
Although COPD cannot be cured, there are measures that can be taken that should relieve symptoms, slow progression and prevent complications.
Read more on myDr website
Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma | Cochrane
Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma
Read more on Cochrane (Australasian Centre) website